Mental Health Press Releases, bring us the latest cutting edge research, and therapies to help Mental Health in our modern society.
ENGLEWOOD, Colo., Oct. 19, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced The Healthcare…
Construction on the project began in March of 2022 with the center opening to patients in September 2023.
“We’re proud to have supported OhioHealth with this complex project,” said Adam Novak, Hammes Healthcare Vice President. “The new center will provide greater ease and convenience for patients in need of comprehensive cancer care in downtown Columbus.”
Hammes Healthcare has served as OhioHealth’s owner’s representative and project manager on more than 30 projects over the past 11 years. Hammes is currently engaged on the new OhioHealth Women’s Center and OhioHealth Trauma and Critical Care Center at Grant, both of which were announced earlier this year.
About Hammes Healthcare
Hammes Healthcare is a national consulting firm that provides real estate and market strategy, facility planning, project management and development services to the healthcare industry. As a reflection of its commitment to the healthcare industry, Hammes has been recognized as one of the nation’s leading healthcare developers by Modern Healthcare’s Construction & Design Survey for 25 consecutive years—including 20 years as No. 1—and by Revista’s Outpatient Healthcare Real Estate Development Report. Headquartered in Milwaukee, Wisconsin, Hammes provides services through a network of regional offices strategically located across the United States. https://www.hammes.com/
Media Contact
Katherine Murray, Hammes, 414.509.2595, [email protected], https://www.hammes.com/
SOURCE Hammes Healthcare
BRANCHBURG, N.J., Oct. 17, 2023 /PRNewswire/ — Lycored will be exhibiting at the Supply Side West expo in Las Vegas, Nevada from October 25th – 26th (booth #2257). Over 18,000 health and nutrition professionals, together with suppliers and buyers, will explore the latest around food,…
The Partnership Innovation Award is presented to the Stevanato Group, Bayer US LLC and Vetter Pharma-Fertigung for the innovation of Diluent PFS for reconstitution and administration of a lyophilized biologic. This partnership innovation involved the close collaboration of the development groups of three parties: the glass barrel manufacturer (Stevanato), the diluent PFS manufacturer (Vetter), and the combination product manufacturer (Bayer). The goals of this partnership were to solve a potential compatibility issue with the diluent PFS and biologic drug product and reduce the gliding forces of the diluent PFS during drug product reconstitution. This collaboration highlights the benefits of bringing together stakeholders with their own process expertise to solve a complex issue with a combination product that benefits each of these stakeholders.
“The companies recognized for the 2023 PDA Drug Delivery Innovation Awards are well-deserving of this honor and I congratulate them for their achievements and tireless effort to move the industry forward,” said PDA President & CEO Glenn Wright. “They, and all the companies that were considered for this award presented technology innovations that will certainly benefit patients worldwide and for that we are all grateful.”
PDA recognizes the award winners each year at its annual Universe of Pre-Filled Syringes and Injection Devices conference, which is held in the U.S. in even years and the EU in odd years.
The PDA Drug Delivery Innovation Awards were created in 2019 to recognize technical innovations advancing the field of bio/pharmaceutical manufacturing. The Innovation Award recognizes a new device, manufacturing process, method, or automation that brings value to the industry; the Partnership Innovation Award recognizes achievement in partnering to successfully launch or introduce a new product to the market or modifying an existing product to make it significantly better or scalable.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. PDA is an ANSI accredited Standards Developing Organization. Go to http://www.pda.org/footer/about-pda to learn more.
Media Contact
Walter Morris, www.pda.org, 1 3016565900, [email protected], www.pda.org
SOURCE Parenteral Drug Association (PDA)
In fact, the prevailing sentiment of AI and ML can be summarized by a line from a Forbes Technology Council article: “No matter how limited or simple the prior datasets, AI can come to a more accurate calculation and conclusion than a human mind.”
What is the real value-add of AI and ML for drug developers? Featured speakers from CAS, architect of the world’s largest human-curated scientific database, share the challenges and opportunities of artificial intelligence; what to keep in mind during the AI implementation journey; and its potential impact on drug discovery teams.
Join this webinar to learn about the strengths, limitations and impact of AI and ML techniques on drug discovery teams.
Join experts from CAS, Jeffrey Wilson, PhD, Data Science Manager; and Gary Gustafson, PhD, Senior Customer Success Specialist, for the live webinar on Tuesday, October 31, 2023, at 10am EDT (3pm CET/EU-Central).
For more information, or to register for this event, visit AI: Challenges, Opportunities and Impact for Drug Discovery Teams.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
EngagedMD, a leading platform for automating patient education and administration, announced today the acquisition of UK-based MD Consents, the parent company of Fertility Consent. This acquisition expands EngagedMD’s global footprint and brings together shared expertise and resources to deliver an enhanced offering to the fertility sector. All members of the dedicated Fertility Consent team will join the combined company ensuring exceptional service and a continued local presence in the UK market.
WASHINGTON, Oct. 16, 2023 /PRNewswire-PRWeb/ — EngagedMD, a leading platform for automating patient education and administration, announced today the acquisition of UK-based MD Consents, the parent company of Fertility Consent. This acquisition expands EngagedMD’s global footprint and brings together shared expertise and resources to deliver an enhanced offering to the fertility sector. All members of the dedicated Fertility Consent team will join the combined company ensuring exceptional service and a continued local presence in the UK market.
By acquiring MD Consents, EngagedMD is set to broaden its reach in the UK and bolster its commitment to supporting patients and clinics through the fertility journey with robust, user-friendly technology. The synergies between the two companies will combine knowledge and technology to improve patient understanding and engagement, which is crucial for the emotionally and medically complex fertility treatment process.
“EngagedMD and Fertility Consent share a common vision – to improve patient experiences through informed decision-making. This acquisition is a significant step forward in realizing that vision on a broader scale,” said Taylor Stein, Co-CEO of EngagedMD.
“We’re excited about the value this union brings to our customers and the advancements we’ll be able to bring to the fertility industry together,” added Jeff Issner, EngagedMD’s Co-CEO.
Fertility Consent is the leader in the UK market with its innovative solutions that simplify complex medical information and the consent process for patients and clinics alike. The combination of the two companies is a strong strategic fit, offering more comprehensive solutions to fertility clinics worldwide.
As EngagedMD and Fertility Consent align their operations, existing customers can look forward to an expanded range of services, better resources, and enhanced customer support.
“The combination of the EngagedMD and Fertility Consent platforms ensures our customers will continue to benefit from a robust consenting platform. We look forward to continuing to be responsive to our customers’ challenges and delivering more innovative features and services,” added Susan Diamond, Director at MD Consents.
The transaction was financed by MonCap, a Colorado-based investment firm actively focused on expanding access to care in the fertility space.
Field Fisher LLP and Polsinelli PC served as advisors to EngagedMD on this transaction.
KBS Corporate, the UK’s leading business sales specialist, advised MD Consents throughout the duration of the transaction.
For more information about EngagedMD, visit www.engagedmd.com.
About EngagedMD
People perform best when they are empowered to do the work they love. The thing doctors and nurses love is taking care of people. EngagedMD automates patient education and admin, two time-intensive functions that get in the way of carers actually caring for people. Medical practices that use EngagedMD save up to 56 minutes of patient time per day. Which means more time for high-quality consults, more space to support patients, and more moments to breathe. The effect? Happier staff taking better care of more people.
About MD Consents
MD Consents is a UK-based company that specializes in providing online consents specifically for fertility clinics. The company recently received the ‘Best e-Consent Solutions Provider, UK in the GHP Global Excellence Awards 2023. The Fertility Consent platform provides patients with consistent and engaging information about their individual treatment, which they can review in the comfort and safety of their own home before electronically completing and signing their consent forms. Fertility Consent reduces the time and resources spent by clinics on the consent process and provides documented evidence of the informed consent process.
Media Contact
Jeff Issner, EngagedMD, 1 202-524-0640, [email protected], engagedmd.com
SOURCE EngagedMD
Experts from around the world meet at the most important forum on global health BERLIN, Oct. 15, 2023 /PRNewswire/ — The World Health Summit 2023, the world’s leading meeting for global health, began Sunday morning in Berlin. From October 15 to 17, international representatives from…
Key Features of JYM Hydration include:
“Proper hydration is a critical aspect of any fitness regimen,” says Dr. Stoppani, who earned his PhD from the University of Connecticut-Storrs and did post-doctorate research at Yale University School of Medicine. “JYM Hydration is designed to provide athletes and fitness enthusiasts with a superior hydration solution that supports their performance goals. It’s backed by science and delivers real results.”
JYM Hydration will be available for purchase at JYMSupps.com starting October 12 and shortly thereafter on Amazon.com. It’s suitable for individuals at all fitness levels, from beginners to professional athletes.
About JYM Supplement Science: JYM Supplement Science is a leading brand in the fitness and nutrition industry, known for its commitment to providing high-quality, science-based supplements. Founded by Dr. Jim Stoppani, a recognized authority in exercise physiology, JYM Supplement Science has helped countless individuals achieve their fitness goals through innovative and effective products.
Media Contact
Mikeal Mann, JYM Supplement Science, 1 8056241532, [email protected]
SOURCE JYM Supplement Science
Keep Safe Care Hires Ashton Rondon as it prepares to expand in Texas, Florida, Arizona, and California
AUSTIN, Texas, Oct. 12, 2023 /PRNewswire-PRWeb/ — Keep Safe Care, launched in Austin, Texas, announces it has hired Ashton Rondon as its Administrative Director to help with the expansion of Keep Safe Care’s Private-Duty-in-a Box2 concept across America. The company launched two years ago to address the growing cost and inefficiencies of the in-home private duty, personal services caregiving sector as well as to rectify some of the issues of low caregiver pay, truancy, and turnover.
Ashton Rondon brings over 15 years of extensive expertise in helping organizations grow and expand organically. As CEO Jeffrey Fry states, “This is a critical role in our expansion plans for Keep Safe Care. As is an experienced public relations, marketing, and project management practitioner, her expertise will be critical to help Keep Safe Care grow from one location in Austin, to many locations throughout the United States.” Mr. Fry continues, “Her know-how and operational and project management expertise will be essential in helping new licensed Affiliates successfully join and integrate into our growing network of Keep Safe Care locations.”
“I have been fortunate enough to have worked with some startups in the past which positively impacted their industries before they went on to be acquired,” states Ashton Rondon. She continues, “I joined Keep Safe Care due in part to what I see as a combination not to only disrupt the in-home care agency franchising model, but more importantly to address the lack of caregiver wages with their 2/3s Rule in caregiver pay. This significant increase in wages without increasing client costs is a calling to me, and I felt that I must be a part of this.”
The 2/3s Rule is Keep Safe Care’s breakthrough ability to pay its caregiver at least two-thirds of whatever the client rate is for any caregiving situation. This has been achieved in large part by how the company has vastly improved the efficiencies of running a private duty, personal care services agency.
Keep Safe Care is planning on initiating the sales of its software licenses for its innovative Private Duty Model in the last quarter of 2023. Mrs. Rondon will help accelerate the roll out of what the Company calls its “Private-Duty-in-a-Box2” concept. These software licenses will be priced at a level that allows Affiliates to open a private duty, in-home personal services caregiving agency for a fraction of the cost of a typical Franchise found in the United States today.
About Keep Safe Care
Keep Safe Care is about revolutionizing the way private duty agencies deliver care and manage caregivers. The company’s innovative approach changes the traditional model of big companies controlling franchisees, while combating the persistent issues of high caregiver truancy and turnover. Keep Safe Care’s goal is to reduce these chronic problems by employing technology to empower caregivers and those who are receiving care. With improved efficiencies, the company’s unique approach holds the promise of increasing a caregiver’s standard wage by 30% to 50%, while at the same time reducing operating costs by 20% to 35% over traditional private duty franchises. For more information go to keepsafecare.com.
Media Contact
Press Officer, Keep Safe Care, 1 (512) 766-0150, [email protected], https://keepsafecare.com
SOURCE Keep Safe Care
Goals include expanded patient access to underserved populations, faster results, and reduced provider burden COLUMBUS, Ohio, Oct. 6, 2023 /PRNewswire/ — Paradigm announced today a collaboration with Bristol Myers Squibb (NYSE: BMY) to build a new end-to-end clinical trial operating…
